Adma Biologics Inc
ADMA - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.56B
Close$
$7.07
36.1% downside
Current Fair Value
36.1% downsideOvervalued by 36.1% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $2.56 Billion |
|---|---|
| Enterprise Value | $2.62 Billion |
| Earnings per Share | $0.62 |
| Beta | 0.77 |
| Outstanding Shares | 228,232,503 |
Return
| Return on Equity | 41.39% |
|---|---|
| Return on Assets | 24.69% |
| Return on Invested Capital | 37.17% |
Valuation & Multiples
| P/E Ratio | 15.85 |
|---|---|
| PEG | 150.51 |
| Price to Sales | 5.53 |
| Price to Book Ratio | 11.06 |
| Enterprise Value to Revenue | 5.12 |
| Enterprise Value to EBIT | 11.6 |
| Enterprise Value to Net Income | 15 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | 0.5 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 12, 2026
EPS Estimate
$0.22
Consensus analyst estimateRevenue Estimate
$149.08 M
Consensus analyst estimateNext Earnings Call
Expected Date
November 4, 2026
EPS Estimate
$0.20
Consensus analyst estimateRevenue Estimate
$138.11 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.0000▼ 65.57% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 1.10%▼ 88.89% |
|---|---|
| Total Invested | $25.08M▼ 98.54% |
| Investors Holding | 90▼ 251.00% |